APE1‐Triggered Inhalable Microsphere (ATIM) for In Situ Non‐Small Cell Lung Cancer Theranostics
Advanced Materials · 2026-06 · 38 (31)
DOI: 10.1002/adma.202520216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 28.04.2026. Verfasst von Xinlin Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, Schoo…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, DNA-(Apurinic or Apyrimidinic Site) Lyase, Theranostic Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Yunnan Province Major Science and Technology Special Project, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Distinguishing benign from malignant pulmonary nodules remains a major clinical challenge, where misdiagnosis may lead to either delayed cancer treatment or unnecessary invasive procedures. Here, we report apurinic/apyrimidinic endonuclease 1 (APE1)‐triggered inhalable microsphere (ATIM) for non‐small cell lung cancer (NSCLC) theranostics by leveraging inhalation delivery and homotypic targeting to accelerate the local enrichment of DNA tetrahedrons (TDNs) in pulmonary tumors, which enables in situ NSCLC theranostics. Upon intracellular recognition of the APE1, entropy‐driven catalytic circuits are activated, triggering nanoparticle aggregation to amplify fluorescence for real‐time tumor imaging and releasing miR‐126‐3p to induce tumor cell apoptosis by suppressing ADAM9. In a mouse orthotopic NSCLC model, the tumor‐bearing group showed a fluorescent intensity 1.67‐fold higher than the healthy group, and the pulmonary accumulation of the ATIM system via inhalation was 3.12‐fold higher than that via intravenous injection, while ATIM therapy significantly reduced the tumor burden to a relative area of 45.3 ± 1.6%. Our results demonstrate that ATIM achieves accurate discrimination between benign and malignant pulmonary nodules while effectively inducing apoptosis in tumor cells. This theranostic system offers a promising dual‐functional platform for precision diagnosis and targeted therapy in early‐stage NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing, China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
- College of Life Science and Laboratory Medicine, Kunming Medical University, Kunming, Yunnan, China.
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, China.
- Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.
ORCID-Profile: Yang Luo
Förderung
- National Natural Science Foundation of China
- Yunnan Province Major Science and Technology Special Project
- Natural Science Foundation of Chongqing
- Municipal Science and Technology Bureau & Health Commission Joint Project of Chongqing
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Guo, X., Qiu, X., Hu, X., Yang, F., Li, H., Wang, X., Lv, L., Xie, J., Yu, Z., Li, P., Xiao, H., Wang, T., Wang, Y., Bernardini, S., Gu, W., Zhang, H., & Luo, Y. (2026). APE1‐Triggered Inhalable Microsphere (ATIM) for In Situ Non‐Small Cell Lung Cancer Theranostics. Advanced Materials, 38(31). https://doi.org/10.1002/adma.202520216
Vancouver
Guo X, Qiu X, Hu X, Yang F, Li H, Wang X, et al. APE1‐Triggered Inhalable Microsphere (ATIM) for In Situ Non‐Small Cell Lung Cancer Theranostics. Advanced Materials. 2026;38(31). doi:10.1002/adma.202520216
BibTeX
@article{Guo2026,
author = {Guo, Xinlin and Qiu, Xiaopei and Hu, Xiaolin and Yang, Fei and Li, Heng and Wang, Xiaoxing and Lv, Linxi and Xie, Jie and Yu, Zhengheng and Li, Pingyun and Xiao, Hui and Wang, Tian and Wang, Yongzhong and Bernardini, Sergio and Gu, Wei and Zhang, Hong and Luo, Yang},
title = {APE1‐Triggered Inhalable Microsphere (ATIM) for In Situ Non‐Small Cell Lung Cancer Theranostics},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {31},
doi = {10.1002/adma.202520216}
}
EUVIMED